Aardvark Therapeutics, Inc.
AARD · XNASCIK 1774857fmd_1GGBMJZ5SETG9Y6VFPT4X43MJFManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2024 to Jun 30, 2026, 10 periods
AI-written
A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.
Loading